FDA Issues Warning on Tianeptine
The US Food and Drug Administration (FDA) has issued a serious alert regarding tianeptine, which is being marketed as a dietary supplement but is infamously referred to as “gas station heroin.” This substance is linked to numerous incidents of overdoses and fatalities.
Tianeptine can be found in places like gas stations, smoke shops, and various online retailers, even though it has never been approved for medical use in the United States. So, what exactly is tianeptine and why is it a cause for concern?
Tianeptine was initially developed in France during the 1960s, gaining approval for treating depression in the late 1980s. Its structure resembles that of tricyclic antidepressants, a class of older drugs, but it operates quite differently in the body. Instead of boosting serotonin levels—which is the typical function of many antidepressants—tianeptine seems to influence the brain’s glutamate system, which plays a key role in learning and memory.
This drug is prescribed in some European, Asian, and Latin American countries under various brand names such as Stablon or Coaxil. However, research has revealed that tianeptine activates the brain’s mu-opioid receptors, the same targets as morphine and heroin, which has contributed to its street nickname.
When taken at prescribed doses, its effects are subtle. But higher doses can lead to euphoria, sedation, and even dependency. Unfortunately, many individuals looking for a high may consume amounts far beyond what is deemed safe.
Despite lacking FDA approval, tianeptine is marketed in the US as a “wellness” product or nootropic intended to boost mood or mental clarity. It is often found in capsule, powder, or liquid form, usually misleadingly labeled as a dietary supplement. This gap in regulation has allowed companies to bypass scrutiny, promoting products like Neptune’s Fix as safe alternatives to traditional treatments. However, they often contain unlisted or harmful ingredients.
Some products have even been identified to contain synthetic cannabinoids and other dangerous substances. US poison control data indicates that calls related to tianeptine exposure have surged by over 500% from 2018 to 2023, with the drug linked to more than 300 poisoning cases in 2024 alone. The FDA’s recent advisory includes product recalls and warnings regarding imports.
Users have turned to platforms like Reddit and other forums to share their experiences—not just the highs but also the challenging withdrawals. Some describe consuming hundreds of pills daily, while others recount the difficulty of quitting, with cravings and relapses reminiscent of traditional opioid addiction.
One issue is that standard toxicology tests do not detect tianeptine, which can lead to missed diagnoses in medical settings. Health professionals may not realize it could be present in patients, especially those experiencing seizures or unusual heart symptoms.
Withdrawal symptoms often mimic those associated with classic opioids. They include anxiety, tremors, insomnia, diarrhea, and muscle pain. Some individuals have even required hospitalization due to severe reactions, such as seizures or respiratory issues.
Legality in the UK
In the UK, tianeptine is not approved for medical use by the Medicines and Healthcare products Regulatory Agency, nor is it classified as a controlled substance. This places it in a legal grey area: technically not permitted for medical application but not illegal to possess.
It is accessible online through international sellers, and a simple search reveals many vendors offering “research-grade” forms. However, there’s little evidence to suggest that tianeptine is widely available in the UK; so far, only one confirmed sample has been detected in a national drug testing database. It hasn’t appeared in recent official briefings or statistics.
This absence might simply mean that no one is looking for it. With no testing protocols established, tianeptine could be present without detection. Its unique chemical structure and effects could easily lead to misdiagnosis as tianeptine might resemble a tricyclic antidepressant overdose or be mistaken for recreational drug use.
It’s conceivable that particularly among people looking for alternatives to harder-to-access opioids or those seeking legal highs, tianeptine has the potential for increased visibility. Given its low profile, online availability, and risk of addiction, it mirrors trends seen in other psychoactive substances that were once easily obtained before regulation kicked in.
The emergence of novel psychoactive substances often follows this pattern, starting online or in head shops before gradually becoming more common until authorities respond. If tianeptine follows this trajectory, significant harm could already be occurring by the time it gains wider recognition.
